MiMedx Group, Inc (MDXG) Shares Bought by California Public Employees Retirement System
California Public Employees Retirement System increased its position in MiMedx Group, Inc (NASDAQ:MDXG) by 60.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 65,100 shares of the medical equipment provider’s stock after acquiring an additional 24,400 shares during the period. California Public Employees Retirement System owned about 0.06% of MiMedx Group worth $975,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Vanguard Group Inc. grew its holdings in shares of MiMedx Group by 11.1% in the second quarter. Vanguard Group Inc. now owns 5,661,111 shares of the medical equipment provider’s stock worth $84,746,000 after acquiring an additional 566,114 shares during the period. Northern Trust Corp grew its holdings in shares of MiMedx Group by 2.2% in the second quarter. Northern Trust Corp now owns 1,381,250 shares of the medical equipment provider’s stock worth $20,677,000 after acquiring an additional 29,265 shares during the period. Pinebridge Investments L.P. grew its holdings in shares of MiMedx Group by 2.9% in the second quarter. Pinebridge Investments L.P. now owns 13,438 shares of the medical equipment provider’s stock worth $201,000 after acquiring an additional 377 shares during the period. GSA Capital Partners LLP bought a new stake in shares of MiMedx Group in the second quarter worth $1,093,000. Finally, New York State Common Retirement Fund grew its holdings in shares of MiMedx Group by 25.8% in the second quarter. New York State Common Retirement Fund now owns 130,805 shares of the medical equipment provider’s stock worth $1,958,000 after acquiring an additional 26,804 shares during the period. 62.65% of the stock is owned by institutional investors.
TRADEMARK VIOLATION WARNING: “MiMedx Group, Inc (MDXG) Shares Bought by California Public Employees Retirement System” was originally reported by Watch List News and is the property of of Watch List News. If you are reading this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this news story can be read at https://www.watchlistnews.com/mimedx-group-inc-mdxg-shares-bought-by-california-public-employees-retirement-system/1699470.html.
MiMedx Group, Inc (NASDAQ MDXG) opened at $12.36 on Monday. The firm has a market capitalization of $1,372.39, a PE ratio of 58.86, a PEG ratio of 2.94 and a beta of 0.91. MiMedx Group, Inc has a one year low of $7.64 and a one year high of $17.47.
MiMedx Group (NASDAQ:MDXG) last released its quarterly earnings data on Thursday, October 26th. The medical equipment provider reported $0.08 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.08. The firm had revenue of $84.60 million during the quarter, compared to analyst estimates of $84.60 million. MiMedx Group had a return on equity of 17.49% and a net margin of 11.64%. The business’s quarterly revenue was up 31.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.06 earnings per share. equities analysts predict that MiMedx Group, Inc will post 0.24 earnings per share for the current fiscal year.
MiMedx Group declared that its board has authorized a share repurchase program on Wednesday, July 26th that allows the company to repurchase $14.00 million in shares. This repurchase authorization allows the medical equipment provider to reacquire up to 0.9% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s leadership believes its stock is undervalued.
Several analysts have issued reports on the company. Needham & Company LLC boosted their price target on MiMedx Group from $20.00 to $21.00 and gave the company a “strong-buy” rating in a report on Tuesday, September 5th. Piper Jaffray Companies reissued a “buy” rating and set a $18.00 price target on shares of MiMedx Group in a report on Sunday, August 20th. BidaskClub raised MiMedx Group from a “hold” rating to a “buy” rating in a report on Thursday, August 10th. Lake Street Capital boosted their price target on MiMedx Group from $16.00 to $18.00 and gave the company a “buy” rating in a report on Friday, July 28th. Finally, Zacks Investment Research lowered MiMedx Group from a “hold” rating to a “sell” rating in a report on Wednesday, October 4th. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. MiMedx Group has a consensus rating of “Hold” and a consensus price target of $15.40.
MiMedx Group Company Profile
MiMedx Group, Inc is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The Company’s Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories.
Receive News & Ratings for MiMedx Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.